SCHEMBL12255286

SCHEMBL12255286

CCCOC(=O)Cc1ccc(CC)s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.41
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HPGD P15428 2/20 0.39
KDM4E B2RXH2 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TSHR P16473 2/20 0.39
ESR1 P03372 1/20 0.39
CHRM1 P11229 1/20 0.39
SLC6A2 P23975 1/20 0.39
KDR P35968 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TP53 P04637 1/20 0.35
MIF P14174 1/20 0.35
NPC1 O15118 1/20 0.35
POLB P06746 1/20 0.35
RAB9A P51151 1/20 0.35
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16564352 0.86 SMN1; SMN2 (0.53) ALDH1A1SMN1; SMN2HPGDTSHRMEN1
SCHEMBL15474206 0.85 SMN1; SMN2 (0.42) ALDH1A1LMNASMN1; SMN2HPGDKDM4E
SCHEMBL12255163 0.84 ALDH1A1 (0.38) ALDH1A1LMNASMN1; SMN2HPGDKDM4E
SCHEMBL12255338 0.82 SMN1; SMN2 (0.43) ALDH1A1LMNASMN1; SMN2HPGDKDM4E
SCHEMBL9880894 0.80 ACACA (0.44) ALDH1A1LMNASMN1; SMN2HPGDHSD17B10
SCHEMBL12255174 0.79 ALDH1A1 (0.35) ALDH1A1LMNASMN1; SMN2HPGDKDM4E
SCHEMBL12028455 0.79 ALDH1A1 (0.35) ALDH1A1LMNASMN1; SMN2HPGDKDM4E
SCHEMBL17490664 0.79 SMN1; SMN2 (0.40) ALDH1A1LMNASMN1; SMN2HPGDKDM4E
SCHEMBL15367929 0.77 ALDH1A1 (0.35) ALDH1A1LMNASMN1; SMN2HPGDKDM4E
SCHEMBL19792672 0.76 TSHR (0.42) ALDH1A1LMNASMN1; SMN2HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8012964-B2 9-substituted 8-oxoadenine compound DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2011-09-06 US disclosed
US-20070190071-A1 9-Substituted 8-oxoadenine compound DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070190071-A1 9-Substituted 8-oxoadenine compound IFNAR1, IL5, IFNG ALDH1A1 3672/4885LMNA 4406/4885SMN1; SMN2 2719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.